1.0Laos Alliance Pharmaceutical Grouphttps://alliancepharmagroup.com/lorich600338<blockquote class="wp-embedded-content" data-secret="ySzzY5epPp"><a href="https://alliancepharmagroup.com/lo/ສິນຄ້າ/alibetezin/">ALIBETEZIN</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://alliancepharmagroup.com/lo/ສິນຄ້າ/alibetezin/embed/#?secret=ySzzY5epPp" width="600" height="338" title="“ALIBETEZIN” — Laos Alliance Pharmaceutical Group" data-secret="ySzzY5epPp" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://alliancepharmagroup.com/wp-includes/js/wp-embed.min.js </script>https://alliancepharmagroup.com/wp-content/uploads/2024/10/Alibetezin.png12801280COMPOSITION Dapagliflozin…………………………………..10mg INDICATIONS Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Indicated to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established cardiovascular disease or multiple cardiovascular risk factors. Chronic Kidney Disease: Indicated to reduce the risk of sustained eGFR decline, end stage kidney disease, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression. Heart Failure: indicated to reduce the risk of cardiovascular death, hospitalization for heart failure (HF), and urgent heart failure visit in adults with HF. PACKAGING: 7 tablets/blister, 2 blisters/box. 7 tablets/blister, 50 blisters/box. Reg No: 08 L 1177/24 Download ALIBETEZIN Drug Registration Certificate ... Read More